MPD: List measures where strain C57BR/cdJ is an outlier

List measures where C57BR/cdJ is an outlier

Click on pulldowns below to see C57BR/cdJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Berndt1:21	Berndt1	ventilator	methacholine	airway resistance (as % of baseline, H₂O pressure) [%] pct_res 34221 MCh challenge (mg/mL): 1 3 10 30	inbred	37	both	9-12wks	N=8	2010

Berndt2:1	Berndt2	plethysmography	methacholine	minute ventilation [mL/min] min_vent 35101 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:41	Berndt2	plethysmography	methacholine	inspiratory flow rate [mL/kg/s] insp_flow 35141 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:48	Berndt2	plethysmography	methacholine	expiratory flow rate [mL/kg/s] exp_flow 35148 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Berndt2:54	Berndt2	plethysmography	methacholine	respiratory flow rate [mL/kg/s] resp_flow 35154 saline 5 MCh 10 MCh 20 MCh response index	inbred	29	both	9-12wks	N=8	2010

Crabbe2:4	Crabbe2	monitoring system	diazepam	horizontal distance traveled, immediately to 15 min post-injection [cm] horiz_DZ 15504 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Crabbe2:14	Crabbe2	body temperature	diazepam	body temperature, 30 min post-injection [°C] temp_DZ 15514 baseline doses mg/kg: 2 4 8 16	inbred	15	m	6-7wks	N=8	1998

Evsikova1:61	Evsikova1	intake monitoring	(none)	food intake [g] food 24761 daily light dark	inbred	14	both	26wks	N=6	2009

Harrill2:15	Harrill2	metabolic panel	DB289	blood urea nitrogen (serum BUN) [mg/dL] BUN 44115 control DB289 difference	inbred	34	f	6-8wks	N=5	2012

Harrill2:25	Harrill2	urinalysis	DB289	urine volume [mL] urine_vol 44125 control DB289 difference	inbred	33	f	6-8wks	N=5	2012

Hawes1:13	Hawes1	slit lamp	(none)	iris transillumination defect [frequency rate] iris_trans_defect 26713	inbred w/CC7	41	both	6-7wks	N=10	2008

Kumar3:13	Kumar3	open field test	(none)	time spent in periphery first 5 min [s] OFPeripheryTime5m 112921	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar3:16	Kumar3	open field test	(none)	time spent in corners first 5 min [s] OFCornerTime5m 112924	inbred w/CC8	62	both	8-14wks	N=20	2021

Kumar4:8	Kumar4	gait analysis	(none)	lateral displacement of base of tail keypoint, mean base_tail_lateral_displacement_mean 114438	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:9	Kumar4	gait analysis	(none)	lateral displacement of base of tail keypoint, median base_tail_lateral_displacement_median 114439	inbred w/CC8	62	both	10-20wks	N=19	2021

Lightfoot1:1	Lightfoot1	running wheel monitoring	(none)	wheel running activity, mean distance [km/d] activity_distance 35701	inbred	41	both	8-16wks	N=6	2010

Peters1:3	Peters1	complete blood count	(none)	measured hemoglobin (HGB) [g/dL] mHGB 6203	inbred w/CC7	43	both	10wks	N=12	2001

Peters4:29	Peters4	complete blood count	(none)	large unstained cells count (LUC; units per volume x 10³) [n/µL] LUC 24329 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:53	Peters4	complete blood count	(none)	large unstained cells differential (LUC; percentage of total WBC) [%] pctLUC 24353 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:65	Peters4	complete blood count	(none)	mean RBC corpuscular hemoglobin content (MCH) [pg] MCH 24365 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:69	Peters4	complete blood count	(none)	mean RBC hemoglobin concentration (MCHC) [g/dL] MCHC 24369 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:77	Peters4	complete blood count	(none)	reticulocyte count (Retic) [n/L] Retic 24377 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Petkova1:1	Petkova1	immune cell quantification	(none)	white blood cell count (WBC; per volume x 10³) [n/µL] WBC 24201 6mo 12mo 18mo 24mo	inbred	32	both		N=7	2007

Petkova1:46	Petkova1	immune cell quantification	(none)	CD4 T cells, effector, as percentage of total CD4 T cells [%] CD4_effector 24246 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Petkova1:51	Petkova1	immune cell quantification	(none)	CD8 T cells, as percentage of total lymphocytes [%] CD8_all 24251 6mo 12mo 18mo 24mo	inbred	32	both		N=8	2007

Project1032:1	Project1032	operant conditioning chamber	(none)	number of infusions earned (intravenous self administration), saline [n] infusions_control 111414 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:11	Project1032	operant conditioning chamber	cocaine	number of infusions earned (intravenous self administration), cocaine [n] infusions_cocaine 111424 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:21	Project1032	operant conditioning chamber	(none)	number of infusions earned (intravenous self administration) combined, saline [n] infusions_combined_control 111434 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=2	2020

Project1032:53	Project1032	operant conditioning chamber	(none)	number of active lever presses (during infusions and timeouts) (intravenous self administration), saline [n] active_control 111466 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:63	Project1032	operant conditioning chamber	cocaine	number of active lever presses (during infusions and timeouts) (intravenous self administration), cocaine [n] active_cocaine 111476 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:79	Project1032	operant conditioning chamber	(none)	number of inactive lever presses (intravenous self administration), saline [n] inactive_control 111492 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=2	2020

Project1032:99	Project1032	operant conditioning chamber	(none)	number of inactive lever presses (intravenous self administration) combined, saline [n] inactive_combined_control 111512 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=2	2020

Project1032:105	Project1032	operant conditioning chamber	(none)	session duration (120 min max) (intravenous self administration), saline [min] session_time_control 111518 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10	HMDP	66	both	9-15wks	N=3	2020

Project1032:125	Project1032	operant conditioning chamber	(none)	session duration (120 min max) (intravenous self administration) combined, saline [min] session_time_combined_control 111538 days 1-4 days 5-7 days 8-10	HMDP	66	both	9-15wks	N=3	2020

Tarantino1:2	Tarantino1	open field test	cocaine	distance traveled, 30 min test [cm] dist 45911 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino1:5	Tarantino1	open field test	cocaine	ambulatory episodes, 30 min test [n] amb_epi 45916 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino1:14	Tarantino1	open field test	cocaine	percentage of time resting, 30 min test [%] rest 45931 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Tarantino2:1	Tarantino2	open field test	ovariectomy	distance traveled, 10 min test [cm] OFT_distance 50601 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:6	Tarantino2	open field test	ovariectomy	time spent mobile, 10 min test [s] OFT_movement 50606 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:16	Tarantino2	open field test	ovariectomy	distance traveled in center of arena, 10 min test [cm] OFT_center_distance 50616 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:21	Tarantino2	open field test	ovariectomy	duration in center of arena, 10 min test [s] OFT_center_duration 50621 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:26	Tarantino2	open field test	ovariectomy	percentage of time spent in center of arena, 10 min test [%] OFT_center_duration_pct 50626 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tarantino2:31	Tarantino2	open field test	ovariectomy	distance traveled in periphery of arena, 10 min test [cm] OFT_thigmotaxis 50631 control ovariectomy	inbred	37	f	10-12wks	N=9	2016

Tordoff3:24	Tordoff3	metabolic panel	(none)	plasma total calcium [mg/dL] total_calcium 10324	inbred w/CC7	40	both	13-15wks	N=10	2002

Wiltshire2:3	Wiltshire2	open field test	fluoxetine	OFT center avoidance, thigmotaxis, 10 min test [%] OFT_thig 38003 control fluoxetine	inbred	30	m	10-11wks	N=11	2011

Wiltshire3:70	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex PTH, relative fluorescence intensity PTH 38170 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Wiltshire3:73	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex S100B, relative fluorescence intensity S100B 38173 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Yuan3:1	Yuan3	metabolic panel	(none)	alanine transaminase (plasma ALT) [IU/L] ALT 24401 6mo 12mo 18mo	inbred	32	both		N=6	2008

Yuan3:31	Yuan3	metabolic panel	(none)	magnesium (serum Mg) [mg/dL] Mg 24431 6mo 12mo 18mo	inbred	32	both		N=6	2008

List measures where C57BR/cdJ is an outlier

Filter Table Results